Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

NO-1886 increases HDL cholesterol by increasing LPL activity

April 7, 1997

Nonoxynol-9 not effective for reducing HIV transmission

April 7, 1997

PPL Therapeutics produces salmon calcitonin in transgenic rabbits

April 4, 1997

New indication for liquid Nutropin approved by FDA

April 4, 1997

Retinoids act as insulin sensitizers in mice

April 3, 1997

New low-dose OC cleared by FDA

April 2, 1997

First Estrophasic OC introduced in the U.S.

April 2, 1997

Lilly continues to develop compounds for postmenopausal syndrome

April 2, 1997

Oxford Molecular/PolyMASC collaborate on development of blood growth factor

April 1, 1997

Ares-Serono and Fournier reach U.S. development and marketing agreement for HRT products

April 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...